Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Other Non-Current Assets (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Other Non-Current Assets for 5 consecutive years, with $5000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets fell 99.59% to $5000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5000.0 through Dec 2025, down 99.59% year-over-year, with the annual reading at $5000.0 for FY2025, 99.59% down from the prior year.
  • Other Non-Current Assets for Q4 2025 was $5000.0 at Werewolf Therapeutics, down from $898000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $21.2 million in Q2 2023, with the low at $5000.0 in Q4 2025.
  • Average Other Non-Current Assets over 5 years is $4.9 million, with a median of $1.2 million recorded in 2021.
  • Peak annual rise in Other Non-Current Assets hit 2038.1% in 2025, while the deepest fall reached 99.59% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $1.2 million in 2021, then grew by 14.24% to $1.4 million in 2022, then skyrocketed by 1423.41% to $21.0 million in 2023, then tumbled by 94.2% to $1.2 million in 2024, then crashed by 99.59% to $5000.0 in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $5000.0, $898000.0, and $122000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.